Conferences & Events News Channel

Immuno-Oncology Conference 2018

26 - 27 September, London, UK.
Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

Ophthalmic Drugs Conference 2018

26 - 27 November 2018, London, UK.
As the global population ages, the incidence of ophthalmic disorders continues to grow, and thus the interest of pharmaceutical and biotech companies is increasingly focused towards innovation of novel approaches for the development of ophthalmic drugs, driving the growth of the global ophthalmic drug market, which is projected to reach £30 billion by 2023.

SMi presents the launch of Cell & Gene Therapy 2018

10 - 11 October, London, UK.
SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October. Cell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therapies and specifically in gene editing, technologies present unlimited research opportunities ranging from novel therapeutic tools to a potential revolution in the field of drug discovery.

SMi presents the 9th Conference on Biosimilars & Biobetters

26 - 27 September 2018, London, UK.
The SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK. Following the success of the previous events in both London and the US, Biosimilars and Biobetters UK 2018 will deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.

SMi presents the 13th Conference on ADMET

9 - 10 July 2018, London, UK.
Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost, and minimise production times.

SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast

7 - 8 June 2018, San Diego, USA.
SMi proudly presents the 2nd Annual Pharmaceutical Microbiology West Coast Conference, in San Diego, USA. The pharmaceutical microbiology field is an ever changing in almost all areas of pharmaceuticals. Therefore, professionals within the field need to be informed and updated on the revised regulations and newly emerging methods and practices.

Introducing SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology this June 2018

13 - 14 June 2018, London, UK.
Although an old process, pharmaceutical freeze drying is ever evolving with new trends and approaches being used for pharmaceutical formulation. In it's 6th year, the conference will cover the most recent advances in Freeze drying technology and discuss the latest ideas in the industry.

Conferences & Events News

Immuno-Oncology Conference 2018

Ophthalmic Drugs Conference 2018

SMi presents the launch of Cell & Gene Therapy 2018

SMi presents the 9th Conference on Biosimilars & Biobetters

SMi presents the 13th Conference on ADMET

SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast

Introducing SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology this June 2018

More Pharma News ...

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs